Natixis, ODDO BHF SCA and Bryan, Garnier & Co Limited acted as Joint Global Coordinators, Joint Lead Managers and Joint Bookrunners (“Joint Global Coordinators, Joint Lead Managers and Joint Bookrunners “).
The Primary Offering resulted in the issuance of 1,028,572 new ordinary shares, representing 14.79% of the Company’s current share capital, at a subscription price per share of €26.25 (issue premium included), for a total amount of €27,000,015. The subscription price was €26.25, representing a 15.32% discount on the closing share price on the Euronext Growth Paris market.
Following the Primary Offering, the Company’s new share capital now consists of 7,982,172 shares, each with a nominal value of €0.70. Based on the cash data (€15.9 million at December 31, 2019) and its forecast expenses, the funds raised as a result of the transaction should enable the Company to achieve its strategic objectives and cover its working capital requirements up to the 2nd quarter of 2023.
Use of the funds raised
The Primary Offering is intended to provide the Company with additional resources to finance the next stages of its growth and prepare for the upgrade of its industrial equipment.
More specifically, the funds raised will be used for the following:
- The second phase of construction of the industrial demonstration plant for recycling through enzyme treatment of PET plastic waste, which is expected to be commissioned in the second quarter of 2021,
- The Company’s operating expenses, including those relating to the industrial demonstration plant up to the end of 2022,
- Participation in a capital increase of CARBIOLICE, a joint venture created by Carbios, Limagrain Ingrédients and the “Sociétés de Projets Industriels” fund operated by Bpifrance, to support the commercial launch of the EVANESTO technology, expected during 2020.
Main features of the offering
A total of 1,028,572 new ordinary shares, with a nominal unit value of €0.70, were issued for the benefit of qualified investors within the meaning of Article 2(e) of (EU) Regulation No.2017/1129 of June 14, 2017, as specified in paragraph of Article L.411-2 of the French Monetary and Financial Code in accordance with the 9th resolution of the Company’s Combined Shareholders’ Meeting held on June 18, 2020.
In addition, 380,952 existing shares held by the Transferors, representing 5.48% of the Company’s current share capital, were transferred to the investors because demand largely exceeded the €20 million threshold set for the Primary Offering.
As such, the order book was easily covered, driven by sustained demand from new and existing institutional investors.
The new shares, representing 14.79% of the Company’s current share capital, on an non-diluted basis, prior to the completion of the Primary Offering (a dilution of 12.89%), were issued by decisions of the Board of Directors on July 21, and 22, 2020 and of the Chief Executive Officer on July 22, 2020, in accordance with the delegation of authority conferred by the 9th resolution approved by the Company’s Combined Shareholders’ Meeting held on June 18, 2020. Concerning the Secondary Offering, the two representatives of Truffle Capital on the Board of Directors did not participate in the discussions or vote on the deliberations of the Board of Directors relating to implementation of the 9th resolution of the Company’s Combined Shareholders’ Meeting held on June 18, 2020.
The issue price for the new shares and the transferred shares was set at €26.25 per share, representing a 15.32% discount on the closing price of Carbios shares on July 22, 2020 (i.e. €31), and a 19.99% discount on the volume-weighted average Carbios share price on the Euronext Growth Paris market of the last 5 trading sessions prior to the price being set, ie. from July 16-22, 2020 inclusive (i.e. €32.81), in accordance with the 9th resolution of the Company’s Combined Shareholders’ Meeting held on June 18, 2020, which set the maximum authorized discount at 20% of the volume-weighted average Carbios share price of the last 5 trading sessions prior to the price being set and the decisions of the Board of Directors meeting held on July 21 and 22, 2020.
For example, a shareholder holding 1% of the Carbios share capital prior to the launch of the Primary Offering will now have a 0.87% stake.
The Company’s share capital will consist of 7,982,172 shares once settlement-delivery is complete.
To the company’s best knowledge, the shareholder base before and after the Offering breaks down as follows: